Molecular Core
分子核心
基本信息
- 批准号:9703532
- 负责人:
- 金额:$ 31.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-20 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:Acupuncture PointsAnalgesicsAstrocytesBehavioralBiological MarkersBlindedBloodBlood CirculationBrainBrain StemCell Culture TechniquesCellsCerebrospinal FluidChronicCore FacilityDependovirusDetectionEarEnzyme-Linked Immunosorbent AssayEvaluationExperimental DesignsFeedbackFlow CytometryFractureGene ExpressionGene Expression ProfilingGenesGenetic TranscriptionGuidelinesImmunoassayImmunologicsIndividualInflammationInflammatoryInjuryInterventionLabelLeukocytesLiquid substanceMapsMeasuresMethodsModelingMolecularMusNeuronsNeuropeptidesNociceptorsOrganPainPathway interactionsPeripheralPersistent painPopulationPostoperative PainProductionRNARecoveryResearch PersonnelResolutionResourcesSamplingSensory GangliaSiteSpinalSpinal CordStimulusStressSubfamily lentivirinaeSyndromeTherapeuticTherapeutic InterventionTibial FracturesTissue SampleTissuesTracerTranscriptTrigeminal PainTrigeminal SystemVariantViralVirus DiseasesVisualWorkafferent nervechemokinechemotherapycytokinedata exchangeinjuredlipid mediatorlipoxin A4nerve injuryneuroinflammationneuronal circuitrypain modelpain signaltool
项目摘要
Molecular Core – Summary
The molecular and immunological characterization of inflammation and injury markers is crucial for the evaluation
of the analgesic complementary approaches proposed in all four projects of this Center. Preliminary studies have
identified sets of pro-inflammatory genes in sensory ganglia, spinal cord, brainstem and brain strongly induced
by the pro-algesic stimuli in the models (chemotherapy, tibial fracture, functional pain syndrome, trigeminal pain)
suggesting that pain has detrimental effects on the function of the CNS and induces inflammatory states in other
organs remote from the site of injury. The Molecular Core will support the Center Projects through the following
Specific Aims: Core Specific Aim 1: Analyze the effects of injuries, prior stress and complementary analgesic
interventions on gene expression in injured tissues and neuronal tissues of the pain pathway. Core Specific
Aim 2: Determine systemic and tissue levels of inflammatory biomarkers and inflammation-resolving lipid
mediators. Core Specific Aim 3: Examine the effects of pain stimuli, prior stress and complementary
interventions on systemic leukocyte profiles and neuroinflammatory cells in neuronal tissues. Core Specific
Aim 4:Provide resources for production of viral tracers for labeling of neuronal circuits engaged in pain models
and by bioelectronic complementary analgesic interventions. Methods include quantitative PCR analysis,
multiplex immunoassays and ELISAs, flow cytometry and cell culture. The Molecular Core will work closely
together with Project Investigators, Behavioral Core, the Statistical Unit of the Administrative Core and external
core facilities to establish a workflow for sample tracing, blinded data transfer and feedback for optimization of
experimental designs.
分子核心——总结
炎症和损伤标志物的分子和免疫学特征对于评估至关重要
该中心所有四个项目中提出的镇痛补充方法。初步研究有
确定了感觉神经节、脊髓、脑干和脑强诱导的促炎基因组
通过模型中的促痛刺激(化疗、胫骨骨折、功能性疼痛综合征、三叉神经痛)
表明疼痛对中枢神经系统功能有不利影响,并会引起其他部位的炎症状态
远离受伤部位的器官。分子核心将通过以下方式支持中心项目
具体目标: 核心具体目标 1:分析受伤、先前压力和补充镇痛药的影响
对疼痛通路受损组织和神经元组织的基因表达进行干预。核心特定
目标 2:确定炎症生物标志物和炎症缓解脂质的全身和组织水平
调解员。核心具体目标 3:检查疼痛刺激、先前压力和补充的影响
对神经组织中全身白细胞谱和神经炎症细胞的干预。核心特定
目标 4:为病毒示踪剂的生产提供资源,用于标记参与疼痛模型的神经元回路
以及生物电子补充镇痛干预措施。方法包括定量 PCR 分析、
多重免疫测定和 ELISA、流式细胞术和细胞培养。分子核心将紧密合作
与项目调查员、行为核心、行政核心统计单位和外部
建立样本追踪、盲数据传输和反馈优化工作流程的核心设施
实验设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SVEN-ERIC JORDT其他文献
SVEN-ERIC JORDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SVEN-ERIC JORDT', 18)}}的其他基金
Nicotine Pouches: Chemical Composition, Toxicity and Behavioral Effects of a New Tobacco Product Category
尼古丁袋:新型烟草产品类别的化学成分、毒性和行为影响
- 批准号:
10673370 - 财政年份:2022
- 资助金额:
$ 31.23万 - 项目类别:
Anesthetic and synthetic cooling flavors in E-cigarettes: Chemistry and respiratory effects modulating nicotine intake
电子烟中的麻醉剂和合成清凉香料:调节尼古丁摄入量的化学和呼吸效应
- 批准号:
9982329 - 财政年份:2018
- 资助金额:
$ 31.23万 - 项目类别:
Mechanisms of Itch in Poison Ivy-Induced Allergic Contact Dermatitis
毒藤引起的过敏性接触性皮炎的瘙痒机制
- 批准号:
9164682 - 财政年份:2016
- 资助金额:
$ 31.23万 - 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
- 批准号:
8900466 - 财政年份:2012
- 资助金额:
$ 31.23万 - 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
- 批准号:
8416589 - 财政年份:2012
- 资助金额:
$ 31.23万 - 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
- 批准号:
8547809 - 财政年份:2012
- 资助金额:
$ 31.23万 - 项目类别:
Counterirritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇的抗刺激作用:分子靶标及其在气道疾病中的作用
- 批准号:
8022797 - 财政年份:2011
- 资助金额:
$ 31.23万 - 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
- 批准号:
8209236 - 财政年份:2011
- 资助金额:
$ 31.23万 - 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
- 批准号:
8605272 - 财政年份:2011
- 资助金额:
$ 31.23万 - 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
- 批准号:
8580913 - 财政年份:2011
- 资助金额:
$ 31.23万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 31.23万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 31.23万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 31.23万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 31.23万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 31.23万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 31.23万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 31.23万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 31.23万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 31.23万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 31.23万 - 项目类别:














{{item.name}}会员




